Search Results - "SUGIO, ASUKA"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer by Sugio, Asuka, Iwasaki, Masahiro, Habata, Shutaro, Mariya, Tasuku, Suzuki, Miwa, Osogami, Hiroyuki, Tamate, Masato, Tanaka, Ryoichi, Saito, Tsuyoshi

    Published in Gynecologic oncology (01-09-2014)
    “…Abstract Objective Ovarian cancer is the leading cause of death from gynecologic cancer, reflecting its often late diagnosis and its chemoresistance. We…”
    Get full text
    Journal Article
  2. 2

    Successful delivery after transabdominal cerclage of uterine cervix for cervical incompetence after radical trachelectomy by Ishioka, Shinichi, Endo, Toshiaki, Baba, Tsuyoshi, Akashi, Yushi, Morishita, Miyuki, Sugio, Asuka, Kanayama, Naohiro, Saito, Tsuyoshi

    “…Pregnancy after radical trachelectomy (RT) has a high risk of prematurity and complications such as preterm premature rupture of the membrane and…”
    Get full text
    Journal Article
  3. 3

    First case of vaginal radical trachelectomy in a pregnant Japanese woman by Iwami, Nanako, Ishioka, Shin-ichi, Endo, Toshiaki, Baba, Tsuyoshi, Nagasawa, Kunihiko, Takahashi, Madoka, Sugio, Asuka, Takada, Sakura, Mariya, Tasuku, Mizunuma, Masahiro, Saito, Tsuyoshi

    Published in International journal of clinical oncology (01-12-2011)
    “…A diagnosis of cervical cancer during pregnancy poses difficult management and ethical problems. Survival of the patient is the foremost concern, but fetal…”
    Get full text
    Journal Article
  4. 4

    BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer by HABATA, SHUTARO, IWASAKI, MASAHIRO, SUGIO, ASUKA, SUZUKI, MIWA, TAMATE, MASATO, SATOHISA, SEIRO, TANAKA, RYOICHI, SAITO, TSUYOSHI

    Published in International journal of oncology (01-07-2016)
    “…Paclitaxel in combination with carboplatin improves survival among patients with susceptible ovarian cancers, but no strategy has been established against…”
    Get full text
    Journal Article
  5. 5

    BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells by Suzuki, Miwa, Iwasaki, Masahiro, Sugio, Asuka, Hishiya, Akinori, Tanaka, Ryoichi, Endo, Toshiaki, Takayama, Shinichi, Saito, Tsuyoshi

    Published in Cancer letters (01-04-2011)
    “…Abstract BAG3 (BCL2-associated athanogene 3) is a member of the BAG family proteins, which interact with and regulate Hsp70. Our aim in the present study was…”
    Get full text
    Journal Article
  6. 6

    BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression by HABATA, SHUTARO, IWASAKI, MASAHIRO, SUGIO, ASUKA, SUZUKI, MIWA, TAMATE, MASATO, SATOHISA, SEIRO, TANAKA, RYOICHI, SAITO, TSUYOSHI

    Published in Oncology reports (01-05-2015)
    “…Approximately 30% of uterine corpus carcinomas are diagnosed at an advanced stage and have a poor prognosis. Our previous study indicated that BCL2-associated…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9